R2053432 |
Cytosporone B;Csn-B;Dothiorelone G |
Cytosporone B (Csn-B; Dothiorelone G) is a naturally occurring nuclear orphan re
|
R2053433 |
H-BETA-ALA-AMC TFA |
H-β-Ala-AMC TFA is a substrate for aminopeptidase.
|
R2053434 |
PF-04745637 |
PF-04745637 is a potent and selective TRPA1 antagonist with an IC50 of 17 nM for
|
R2053435 |
JMS-17-2 |
JMS-17-2 is a potent and selective CX3CR1 antagonist with an IC50 of 0.32 nM. JM
|
R2053436 |
GRL0617 |
GRL0617 is a potent, selective and competitive noncovalent inhibitor of severe a
|
R2053437 |
Apcin |
Apcin, a ligand of Cdc20, is a potent and competitive anaphase-promoting complex
|
R2053438 |
CL2A-SN-38 |
CL2A-SN-38 is a drug-linker conjugate composed of a potent a DNA Topoisomerase I
|
R2053439 |
BMS-1001 |
BMS-1001 is a potent inhibitor of PD-1/PD-L1 interaction with IC50 of 2.25 nM in
|
R2053440 |
Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH |
Fmoc-Ser(O-α-D-GalNAc(OAc)3)-OH is a drug for cancer.
|
R2053441 |
FMOC-THR(GALNAC(AC)3-ALPHA-D)-OH |
AZP-531 is an analogue of unacylated ghrelin designed to improve glycaemic contr
|
R2053443 |
ME0328 |
ME0328 is a potent and selective ARTD3/PARP3 inhibitor with an IC50 of 0.89±0.28
|
R2053444 |
BAY-985 |
BAY-985 is a highly potent, orally active and selective ATP-competitive dual inh
|
R2053445 |
GSK180 |
GSK180 is a selective, competitive, and potent inhibitor of kynurenine-3-monooxy
|
R2053446 |
VU0238441 |
VU0238441 is a potent agonist of human Muscarinic acetylcholine receptor M5 with
|
R2053447 |
ML-109 |
ML-109 is a potent and full thyroid stimulating hormone receptor (TSHR) agonist,
|
R2053448 |
C75 |
trans-C75 ((±)-C75) is an enantiomer of C75. C75 is a synthetic fatty-acid synth
|
R2053449 |
NS-3-008(HCl) |
NS-3-008 hydrochloride is an orally active transcriptional inhibitor of G0/G1 sw
|
R2053450 |
BO-264 |
BO-264 is a highly potent and orally active transforming acidic coiled-coil 3 (T
|
R2053452 |
Vonafexor |
Vonafexor (EYP001) is a selective FXR agonist with anti-HBV effects.
|
R2053454 |
RBN-2397 |
RBN-2397 is a potent, accross species and orally active NAD+ competitive inhibit
|
R2053455 |
VU0119498 |
VU0119498 is an agonist of M1 muscarinic receptor with EC50 of 3.1 μM. VU0119498
|
R2053456 |
X-115(Ewha-18278) |
APX-115 free base (Ewha-18278 free base) is a potent, orally active pan NADPH ox
|
R2053457 |
LC3-mHTT-IN-AN1 (Compound AN1) |
LC3-mHTT-IN-AN1 (Compound AN1) is a mHTT-LC3 linker compound, which interacts wi
|
R2053458 |
VU0238429 |
VU 0238429 is positive allosteric modulator of muscarinic acetylcholine receptor
|
R2053459 |
XP-59 |
XP-59 is a potent inhibitor of the SARS-CoV Mpro, with a Ki of 0.1 μM.
|